From lipids to lipid nanoparticles to mRNA vaccines

Lipid nanoparticles are essential to mRNA vaccines. The groundwork for lipid-based drug delivery systems was laid more than 40 years ago in the lab of Pieter Cullis, Professor at the University of British Columbia. Nature Reviews Materials talks to Pieter Cullis about the history and future of lipid...

Descripción completa

Detalles Bibliográficos
Autor principal: Horejs, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Q&A
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454296/
https://www.ncbi.nlm.nih.gov/pubmed/34567796
http://dx.doi.org/10.1038/s41578-021-00379-9
_version_ 1784570455696343040
author Horejs, Christine
author_facet Horejs, Christine
author_sort Horejs, Christine
collection PubMed
description Lipid nanoparticles are essential to mRNA vaccines. The groundwork for lipid-based drug delivery systems was laid more than 40 years ago in the lab of Pieter Cullis, Professor at the University of British Columbia. Nature Reviews Materials talks to Pieter Cullis about the history and future of lipid nanoparticle–nucleic acid drugs.
format Online
Article
Text
id pubmed-8454296
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-84542962021-09-21 From lipids to lipid nanoparticles to mRNA vaccines Horejs, Christine Nat Rev Mater Q&A Lipid nanoparticles are essential to mRNA vaccines. The groundwork for lipid-based drug delivery systems was laid more than 40 years ago in the lab of Pieter Cullis, Professor at the University of British Columbia. Nature Reviews Materials talks to Pieter Cullis about the history and future of lipid nanoparticle–nucleic acid drugs. Nature Publishing Group UK 2021-09-21 2021 /pmc/articles/PMC8454296/ /pubmed/34567796 http://dx.doi.org/10.1038/s41578-021-00379-9 Text en © Springer Nature Limited 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Q&A
Horejs, Christine
From lipids to lipid nanoparticles to mRNA vaccines
title From lipids to lipid nanoparticles to mRNA vaccines
title_full From lipids to lipid nanoparticles to mRNA vaccines
title_fullStr From lipids to lipid nanoparticles to mRNA vaccines
title_full_unstemmed From lipids to lipid nanoparticles to mRNA vaccines
title_short From lipids to lipid nanoparticles to mRNA vaccines
title_sort from lipids to lipid nanoparticles to mrna vaccines
topic Q&A
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454296/
https://www.ncbi.nlm.nih.gov/pubmed/34567796
http://dx.doi.org/10.1038/s41578-021-00379-9
work_keys_str_mv AT horejschristine fromlipidstolipidnanoparticlestomrnavaccines

Ejemplares similares